KINSHASA, November 11, 2026 — The Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo has passed 11,000 reported infections, with the death toll continuing to rise as insecurity, difficult access to health facilities and gaps in contact tracing complicate efforts to contain the disease.
The Associated Press reported on Wednesday that the outbreak had reached 11,042 infections and 5,387 deaths, making it the deadliest Ebola outbreak recorded in the DRC and the second-largest documented globally. The figures are higher than the latest dated international surveillance totals available earlier this week: the European Centre for Disease Prevention and Control (ECDC) reported 10,990 confirmed cases and 5,354 deaths as of November 9, using data through November 8.
The World Health Organization’s November 6 outbreak bulletin recorded 10,668 confirmed cases and 5,198 deaths as of November 3. The reporting cut-offs matter: outbreak figures are updated at different times and are subject to reconciliation by national authorities. The latest AP tally should therefore be read alongside the dated surveillance snapshots rather than treated as a directly comparable same-day count.
Transmission Remains Concentrated In Eastern Provinces
The current outbreak was declared on May 15, 2026, after laboratory analysis identified Bundibugyo virus in Ituri Province. It has since affected eight DRC provinces: Ituri, Nord-Kivu, Sud-Kivu, Tshopo, Haut-Uélé, Bas-Uélé, Sud-Ubangi and Nord-Ubangi.
In its November 6 bulletin, WHO said confirmed cases had been identified in 67 health zones, with active transmission continuing in 51. Ituri remained the most affected province, followed by Nord-Kivu. The agency recorded 1,463 new confirmed cases in the 21 days to November 3, including 710 in Ituri and 640 in Nord-Kivu. The concentration of cases in these two provinces places sustained pressure on local treatment, surveillance and emergency-response systems.
WHO also highlighted the number of deaths occurring outside treatment centres. Of 512 deaths reported in the DRC after October 21 in the data available for its November 6 update, 335 occurred in communities and 177 in treatment centres. That pattern points to persistent problems with early detection, timely referral and access to care, rather than simply a shortage of hospital beds.
Conflict, Mobility And Community Trust Shape The Response
Health agencies say the outbreak is unfolding in areas affected by armed conflict, population displacement and difficult transport conditions. Insecurity can prevent medical teams from reaching patients, delay laboratory testing and interrupt the tracing of people who may have been exposed. The U.S. Centers for Disease Control and Prevention has also cited limited health infrastructure, shortages of infection-prevention supplies, violence against health workers, population movement and misinformation as major obstacles.
Contact tracing remains a particular concern. ECDC reported that 79.2% of identified contacts were under follow-up in affected DRC provinces in the data available for November 9. WHO’s earlier bulletin also showed contact-monitoring performance below the 95% operational target in several provinces. When a contact cannot be located or monitored, a potential chain of transmission can remain undetected until another person becomes ill.
Community engagement is therefore central to the response. Health authorities need trusted local leaders, clear explanations of symptoms and transmission, safe and respectful care, and reliable access to treatment. Misinformation or fear can discourage people from reporting symptoms and seeking help, making an already difficult outbreak harder to control.
.jpg){kind=link}
Regional Cases Prompt Cross-Border Monitoring
The outbreak has also required a regional response. WHO says cases have been reported in five countries since May: the DRC, France, Kenya, Nigeria and Uganda. The outbreaks in France and Uganda were declared controlled in August, while Kenya and Nigeria continued response activities following imported cases.
Nigeria reported one confirmed case on October 20 in a woman who had travelled from Uganda and developed symptoms after arriving in the country. ECDC said she was medically evacuated to Switzerland on October 26, and that 62 contacts had been identified. By November 5, seven of those contacts had completed the 21-day quarantine period. The Nigerian case demonstrates why cross-border surveillance and rapid communication between health authorities remain important, but it does not mean that widespread community transmission has been established in Nigeria.
Kenya had reported nine cases and two deaths by November 9, according to ECDC. The last confirmed case in that cluster was reported on October 20. The agency said six patients had recovered by November 6, while one remained under treatment at the time of its update.
Vaccine Research Advances, But No Licensed Bundibugyo-Specific Product Is Available
The virus responsible for the outbreak is the Bundibugyo species of Ebola, for which no licensed vaccine or specific treatment is currently available. That distinction is important because vaccines developed for the more familiar Zaire ebolavirus cannot automatically be assumed to provide protection against Bundibugyo virus.
There has nevertheless been progress in research. On November 4, WHO announced that two additional candidates — Oxford and Serum Institute of India’s ChAdOx1 vaccine and Moderna’s mRNA-1469 — had been recommended for evaluation in the Tumaini clinical trial in the DRC, subject to national approvals. The trial uses a ring-vaccination approach, offering vaccination to contacts of confirmed cases and their contacts. WHO said results from the vaccine trial are expected in early 2027.
WHO-sponsored treatment research is also evaluating potential options, including the monoclonal antibody MBP134 and the antiviral remdesivir, alone or in combination. These are research candidates, not established cures. For now, early diagnosis, supportive clinical care, infection prevention, safe burials, contact tracing and community cooperation remain essential parts of the response.
What Happens Next
The immediate test for authorities is whether they can improve access to affected communities and raise contact follow-up while maintaining safe conditions for health workers. The concentration of recent cases in Ituri and Nord-Kivu means that progress in those provinces will heavily influence the national trajectory. Regional preparedness will also matter because travel and trade links can move exposed people across borders before symptoms appear.
WHO has advised against general restrictions on travel or trade with affected countries, favouring targeted preparedness and surveillance measures. ECDC continues to monitor the situation and says the true scale may be higher than reported because of gaps in epidemiological information and incomplete contact follow-up.
HeadlinesXtra Analysis
The latest figures show that this is not simply a matter of the outbreak crossing a numerical threshold. The deeper challenge is the combination of a virus with limited medical countermeasures and an operating environment where conflict, poor infrastructure and mistrust can weaken the basic public-health functions needed to stop transmission.
The fact that most deaths in WHO’s recent reporting occurred in communities is particularly significant. It suggests that people are still dying before they can reach treatment centres, whether because illness is recognised too late, transport is unavailable, insecurity blocks access or families hesitate to seek care. Expanding treatment capacity is important, but it will not be enough without community-level detection and safe referral pathways.
The vaccine candidates entering the Tumaini trial are an important scientific development, but they should not be presented as an immediate solution. Results are not expected until 2027, and effectiveness must be established through rigorous evaluation. In the meantime, governments and partners must invest in surveillance, protective equipment, reliable transport, health-worker security and communication that communities trust.
For Nigeria and its neighbours, the most proportionate response is sustained vigilance rather than alarm. The imported case recorded in October underlines the need for functioning contact tracing and coordinated border preparedness. It does not justify treating every traveller or community as a source of infection. Transparent reporting, targeted monitoring and rapid access to care offer a stronger route to containment than broad measures that disrupt trade or deepen public fear.
Sources And Further Reading
- Associated Press — Ebola tops 11,000 cases in Congo’s deadliest outbreak (November 11, 2026)
- World Health Organization — Bundibugyo Ebola disease outbreak update (November 6, 2026)
- European Centre for Disease Prevention and Control — Multi-country Ebola outbreak update (November 10, 2026)
- U.S. Centers for Disease Control and Prevention — Ebola outbreak: current situation (November 10, 2026)
- World Health Organization — Two new candidate vaccines to join Ebola trial (November 4, 2026)
- Reuters — WHO says Congo Ebola outbreak spreads to two new health zones (September 25, 2026)